Press release - 18 February 2014 13:40

Chr. Hansen wins research award at Probiota 2015

Chr. Hansen wins emerging science award for innovative microbe screening platform

da Mosbech Smith, PhD student in Chr. Hansen Health & Nutrition Discovery, presented results from a project where the platform was used to identify yeasts capable of modulating human inflammatory responses.

At this year’s Probiota congress in Amsterdam, a panel of leading industry experts selected Chr. Hansen as one of three emerging science winners, for their in vitro microbe screening platform. The platform enables identification of microbes capable of modifying the function of human immune cells.

These capabilities are expected to exert a health benefit in conditions of excessive inflammation and the platform is currently being expanded to be used in Chr. Hansen’s large bacteria screening programs.

Important understanding in developing probiotic products
Benedicte Flambard, Vice President, Chr. Hansen Health & Nutrition Innovation, comments on the results:

“In the support of our current probiotic products, and in the development of the next generation products, generating high quality scientific data and maintaining the best possible scientific documentation is key. We build our understanding of all our microbes using multiple in vitro and ex vivo platforms along with manufacturing characteristics and this award demonstrates the importance of such insight.”

Ida Mosbech Smith was also acknowledged for her study at the International Probiotics & Prebiotics Scientific Conference 2014, where she won the “Young Scientist Award”.

More information about the program
For more information on Chr. Hansen’s innovation programme, do not hesitate to contact Benedicte Flambard, dkbef@chr-hansen,com, +45 24 47 39 97

or visit the probiotic website: http://www.chr-hansen.com/probiotics

₂

Topics

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. All solutions are based on strong research and development competencies and significant technology investments. The company enjoys market leadership in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors Division. There are more than 2,300 dedicated employees in over 30 countries.

Contacts

Helle Rexen

Press contact Media relations officer DKHRE@chr-hansen.com +45 20 74 28 40

Kathrine Westermann

Press contact Head of Media Relations DKKAWN@chr-hansen.com +45 23 81 55 95

About us

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 150 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 50,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As one of the world’s most sustainable companies, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.